Metabolic Syndrome in Patients with Knee Osteoarthritis

Osteoarthritis is one of the most common clinical conditions causing severe chronic and restrictive disability, especially in elderly people.

Of those aged 60 years and older, 10% of men and 13% of women had symptomatic knee OA . As the population ages and the prevalence of obesity and overweight generaly rises , the percentage of persons affected with symptomatic knee OA will likely increase.

The clinical manifestations in patients are joint pain, stiffness, and functional limitation .

Among all body joints; knee joint is the most commonly affected joint with osteoarthritis and accounts almost for four-fifth of the osteoarthritis burden worldwide .

Epidemiological research has shown an encouraging relationship between OA and metabolic syndrome , MetS include hypertension, dyslipidemia, hyperglycemia, and obesity .Recently, metabolic OA has been nominated as the fifth component of MetS .

Studies reported that adipokines may contribute to the development of osteoarthritis (OA) by increasing inflammatory cytokines and growth factors, modifying insulin sensitivity, and triggering processes that break down cartilage.

Studies also reported that hypertension can be linked to osteoarthritis through astherosclerosis which cause subchondral bone ischemia accelerating OA progression.

Furthermore, researches have linked glucose levels to knee osteoarthritis , supporting the possibility of pathophysiological mechanisms such oxidative stress in the chondrocytes and Cartilage-associated production of advanced glycation end products (AGEs) .

Inclusion

• Both males and female .
• Age between 30 and 70 years old.
• Patient fulfill the criteria of knee osteoarthritis .

Exclusion criteria

• Patients known to have rheumatological disease .
• Patients with meniscal or cruciate ligament injury .
• Patients with previous knee surgery .